Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74(3):229-263. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Bando H, Ohtsu A, Yoshino T (2023) Therapeutic landscape and future direction of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 20(5):306-322. https://doi.org/10.1038/s41575-022-00736-1.

Article  CAS  PubMed  Google Scholar 

Dakal TC, Bhushan R, Xu C, Gadi BR, Cameotra SS, Yadav V, Maciaczyk J, Schmidt-Wolf I, Kumar A, Sharma A (2024) Intricate relationship between cancer stemness, metastasis, and drug resistance. MedComm (2020). 5(10):e710. https://doi.org/10.1002/mco2.710.

Article  CAS  Google Scholar 

Gaiani F, Marchesi F, Negri F, Greco L, Malesci A, de'Angelis GL, Laghi L (2021) Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes. Int J Mol Sci. https://doi.org/10.3390/ijms22105246.

Article  PubMed  PubMed Central  Google Scholar 

Johnson D, Chee CE, Wong W, Lam R, Tan I, Ma B (2024) Current advances in targeted therapy for metastatic colorectal cancer - Clinical translation and future directions. Cancer Treat Rev. 125:102700. https://doi.org/10.1016/j.ctrv.2024.102700.

Article  CAS  PubMed  Google Scholar 

Salva de Torres C, Baraibar I, Saoudi González N, Ros J, Salva F, Rodríguez-Castells M, Alcaraz A, García A, Tabernero J, Élez E (2024) Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer. Int J Mol Sci. https://doi.org/10.3390/ijms25136967.

Article  PubMed  PubMed Central  Google Scholar 

Śmiech M, Leszczyński P, Kono H, Wardell C, Taniguchi H (2020) Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks. Genes (Basel). https://doi.org/10.3390/genes11111342.

Article  PubMed  Google Scholar 

Song Y, Chen M, Wei Y, Ma X, Shi H (2024) Signaling pathways in colorectal cancer implications for the target therapies. Mol Biomed. 5(1):21. https://doi.org/10.1186/s43556-024-00178-y.

Article  PubMed  PubMed Central  Google Scholar 

Kopetz S, Murphy DA, Pu J, Ciardiello F, Desai J, Van Cutsem E, Wasan HS, Yoshino T, Saffari H, Zhang X, Hamilton P, Xie T, Yaeger R, Tabernero J (2024) Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial. Nat Med. 30(11):3261-3271. https://doi.org/10.1038/s41591-024-03235-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benson AB, Venook AP, Adam M, Chang G, Chen YJ, Ciombor KK, Cohen SA, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Haste P, Hecht JR, Hoffe S, Hunt S, Hussan H, Johung KL, Joseph N, Kirilcuk N, Krishnamurthi S, Malla M, Maratt JK, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Shogan B, Skibber JM, Sofocleous CT, Tavakkoli A, Willett CG, Wu C, Gurski LA, Snedeker J, Jones F (2024) Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. https://doi.org/10.6004/jnccn.2024.0029.

Tan L, Tran B, Tie J, Markman B, Ananda S, Tebbutt NC, Michael M, Link E, Wong SQ, Chandrashekar S, Guinto J, Ritchie D, Koldej R, Solomon BJ, McArthur GA, Hicks RJ, Gibbs P, Dawson SJ, Desai J (2023) A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study. Clin Cancer Res. 29(6):1017-1030. https://doi.org/10.1158/1078-0432.CCR-22-3094.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caputo F, Santini C, Bardasi C, Cerma K, Casadei-Gardini A, Spallanzani A, Andrikou K, Cascinu S, Gelsomino F (2019) BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights. Int J Mol Sci. https://doi.org/10.3390/ijms20215369.

Article  PubMed  PubMed Central  Google Scholar 

Taieb J, Lapeyre-Prost A, Laurent Puig P, Zaanan A (2019) Exploring the best treatment options for BRAF-mutant metastatic colon cancer. Br J Cancer. 121(6):434-442. https://doi.org/10.1038/s41416-019-0526-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inchingolo R, Maino C, Cannella R, Vernuccio F, Cortese F, Dezio M, Pisani AR, Giandola T, Gatti M, Giannini V, Ippolito D, Faletti R (2023) Radiomics in colorectal cancer patients. World J Gastroenterol. 29(19):2888-2904. https://doi.org/10.3748/wjg.v29.i19.2888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nie K, Shi L, Chen Q, Hu X, Jabbour SK, Yue N, Niu T, Sun X (2016) Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI. Clin Cancer Res. 22(21):5256-5264. https://doi.org/10.1158/1078-0432.CCR-15-2997.

Article  PubMed  PubMed Central  Google Scholar 

Huang X, Cheng Z, Huang Y, Liang C, He L, Ma Z, Chen X, Wu X, Li Y, Liang C, Liu Z (2018) CT-based Radiomics Signature to Discriminate High-grade From Low-grade Colorectal Adenocarcinoma. Acad Radiol. 25(10):1285-1297. https://doi.org/10.1016/j.acra.2018.01.020.

Article  PubMed  Google Scholar 

Cui Y, Liu H, Ren J, Du X, Xin L, Li D, Yang X, Wang D (2020) Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer. Eur Radiol. 30(4):1948-1958. https://doi.org/10.1007/s00330-019-06572-3.

Article  CAS  PubMed  Google Scholar 

Shin J, Seo N, Baek SE, Son NH, Lim JS, Kim NK, Koom WS, Kim S (2022) MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy. Radiology. 303(2):351-358. https://doi.org/10.1148/radiol.211986.

Article  PubMed  Google Scholar 

Badic B, Da-Ano R, Poirot K, Jaouen V, Magnin B, Gagnière J, Pezet D, Hatt M, Visvikis D (2022) Prediction of recurrence after surgery in colorectal cancer patients using radiomics from diagnostic contrast-enhanced computed tomography: a two-center study. Eur Radiol. 32(1):405-414. https://doi.org/10.1007/s00330-021-08104-4.

Article  PubMed  Google Scholar 

Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY (2016) Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer. J Clin Oncol. 34(18):2157-2164. https://doi.org/10.1200/JCO.2015.65.9128.

Article  PubMed  Google Scholar 

Wu J, Lv Y, Wang N, Zhao Y, Zhang P, Liu Y, Chen A, Li J, Li X, Guo Y, Wu T, Liu A (2019) The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer. Eur Radiol. 29(7):3782-3790. https://doi.org/10.1007/s00330-019-06144-5.

Article  PubMed  Google Scholar 

Lam A, Fernando D, Sirlin CC, Nayyar M, Goodwin SC, Imagawa DK, Lall C (2017) Value of the portal venous phase in evaluation of treated hepatocellular carcinoma following transcatheter arterial chemoembolisation. Clin Radiol. 72(11):994.e9-994.e16. https://doi.org/10.1016/j.crad.2017.07.003.

Article  CAS  PubMed  Google Scholar 

Gökmen İ, Taştekin E, Demir N, Özcan E, Akgül F, Hacıoğlu MB, Erdoğan B, Topaloğlu S, Çiçin İ (2023) Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer. Curr Issues Mol Biol. 45(10):7803-7812. https://doi.org/10.3390/cimb45100491.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen D, Su X, Zhu L, Jia H, Han B, Chen H, Liang Q, Hu C, Yang H, Liu L, Li P, Wei W, Zhao Y (2023) Papillary thyroid cancer organoids harboring BRAF(V600E) mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies. J Transl Med. 21(1):9. https://doi.org/10.1186/s12967-022-03848-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Dong D, Fang M, Zhu Y, Zang Y, Liu Z, Zhang H, Ying J, Zhao X, Tian J (2018) Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer. Eur Radiol. 28(5):2058-2067. https://doi.org/10.1007/s00330-017-5146-8.

Article  PubMed  Google Scholar 

Xue T, Peng H, Chen Q, Li M, Duan S, Feng F (2022) Preoperative Prediction of BRAF Mutation Status in Colorectal Cancer Using a Clinical-radiomics Model. Acad Radiol. 29(9):1298-1307. https://doi.org/10.1016/j.acra.2021.12.016.

Article  PubMed  Google Scholar 

Yan R, Qin S, Xu J, Zhao W, Xin P, Xing X, Lang N (2024) A comparison of 2D and 3D magnetic resonance imaging-based intratumoral and peritumoral radiomics models for the prognostic prediction of endometrial cancer: a pilot study. Cancer Imaging. 24(1):100. https://doi.org/10.1186/s40644-024-00743-2.

Article  PubMed  PubMed Central